Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 270, Issue 4 33-4, 1996, Pages

  Oehri, Martin ^b   Ninnis, Ronald ^b   Girard, Jürg ^b   Frey, Felix J ^b   Keller, Ulrich ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

free fatty acids; glucose kinetics; insulin secretion; insulin like growth factor I; leucine kinetics; stable isotopes

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; LEUCINE; METHYLPREDNISOLONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; ARTICLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NORMAL HUMAN; OXIDATION; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0029927781     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.270.4.e552     Document Type: Article

References (32)

1. Baxter, J. D., and G. G. Rousseau. Glucocorticoid hormone action: an overview. In: Glucocorticoid Hormone Action, edited by J. D. Baxter and G. G. Rousseau. New York: Springer-Verlag, 1979, p. 1-24.
2. Baxter, R. C. Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatr. Scand. Suppl. 372: 107-114, 1991.
3. Cherrington, A. D., J. L. Chiasson, A. S. Liljenquist, A. S. Jennings, U. Keller, and W. W. Lacy. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J. Clin. Invest. 58: 1407-1418, 1976.
4. Clemmons, D. R., B. A. Smith, and L. E. Underwood. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J. Clin. Endocrinol. Metab. 75: 234-238, 1992.
5. Clemmons, D. R., D. K. Snyder, R. Williams, and L. E. Underwood. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. J. Clin. Endocrinol. Metab. 64: 878-883, 1986.
6. Conover, C. A., G. D. Divertie, and P. D. Lee. Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acta Endocrinol. 128: 140-143, 1993.
7. Daughaday, W. H. A personal history of the origin of the somatomedin hypothesis and recent challenges to its validity. Perspect. Biol. Med. 32: 194-211, 1989.
8. Elahi, D., D. M. McAloon, N. K. Fukagawa, A. L. Sclater, G. A. Wong, R. P. Shannon, K. L. Minaker, J. M. Miles, A. H. Rubenstein, C. J. Vandepol, H.-P. Guler, W. Good, J. J. Seaman, and R. R. Wolfe. Effects of recombinant human IGF-I on glucose and leucine kinetics in men. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E831-E838, 1993.
9. Fanelli, C., S. Calderone, L. Epifano, A. De Vincenzo, F. Modarelli, S. Pampanelli, G. Periello, P. De Feo, P. Brunetti, J. E. Gerieh, and G. B. Bolli. Demonstrating of a critical role fore free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization. J. Clin. Invest. 92: 1617-1622, 1993.
10. Frey, F. J., B. M. Frey, and L. Z. Benet. Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma. Clin. Chem. 25: 1944-1947, 1979.
11. Girard, J., T. Erb, A. Pampalone, A. N. Eberle, and J. B. Baumann. Growth hormone in urine: development of an ultrasensitive assay applicable to plasma and urine. Horm. Res. 28: 71-80, 1987.
12. Goldstein, R. E., D. H. Wasserman, P. Owen, O. P. McGuinness, D. B. Lacy, A. D. Cherriugton, and N. N. Abumrad. Effects of chronic elevation in plasma cortisol on hepatic carbohydrate metabolism. Am. J. Physiol. 264 (Endocrinol. Metab. 27): E119-E127, 1993.
13. Grimble, G. K., M. F. West, A. B. Acuti, R. G. Rees, M. K. Hunjan, J. D. Webster, P. G. Frost, and D. B. Silk. Assessment of an automated chemiluminescence nitrogen analyzer for routine use in clinical nutrition. J. Parenter. Enteral Nutr. 12: 100-106, 1988.
14. Guler, H.-P., J. Zapf, C. Schmid, and E. R. Froesch. Insulin-like growth factors I and II in healthy man. Estimation of half-lives and production rates. Acta Endocrinol. 121: 753-758, 1989.
15. Horber, F. F., and M. W. Haymond. Human growth hormone prevents the protein catabolic effects of prednisone in humans. J. Clin. Invest. 86: 265-272, 1990.
16. Horber, F. F., M. Marsh, and M. W. Haymond. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes 40: 141-149, 1990.
17. Hussain, M. A., O. Schmitz, A. Mengel, Y. Glatz, J. S. Christiansen, J. Zapf, and E. R. Froesch. Comparison of the effects of growth homone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J. Clin. Invest. 94: 1126-1133, 1994.
18. Hussain, M. A., O. Schmitz, A. Mengel, A. Keller, J. S. Christiansen, J. Zapf, and E. R. Froesch. Insulin-like growth factor 1 stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J. Clin. Invest. 92: 2249-2256, 1993.
19. Kupfer, S. R., L. E. Underwood, R. C. Baxter, and D. R. Clemmons. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J. Clin. Invest. 91: 391-396, 1993.
20. Laager, R., R. Ninnis, and U. Keller. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans. J. Clin. Invest. 92: 1903-1909, 1993.
21. Lieberman, S. A., G. E. Butterfield, D. Harrison, and A. R. Hoffman. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 78: 404-410, 1994.
22. Livingston, N., T. Pollare, H. Lithell, and P. Arner. Characterisation of insulin-like growth factor I receptor in skeletal muscles of normal and insulin resistant subjects. Diabetologia 31: 871-877, 1988.
23. Louard, R. J., R. Bhushan, R. A. Gelfand, E. J. Barrett, and R. S. Sherwin. Glucocorticoids antagonize insulin's antiproteolytic action on skeletal muscle in man. J. Clin. Endocrinol. Metab. 79: 278-284, 1994.
24. Mauras, N., and B. Beaufrere. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminished the protein catabolic effects of prednisone in humans without a diabetogenic effect. J. Clin. Endocrinol. Metab. 80: 869-874, 1995.
25. Mauras, N., F. F. Horber, and M. W. Haymond. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans. J. Clin. Endocrinol. Metab. 75: 1192-1197, 1992.
26. Pagano, G., P. Cavallo-Perin, M. Cassader, A. Bruno, A. Ozzello, P. Masciola, A. M. Dall'omo, and B. Imbimbo. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J. Clin. Invest. 72: 1814-1820, 1983.
27. Randle, P. J., A. L. Kerbey, and J. Espinal. Mechanisms decreasing glucose oxidation in diabetes and starvation. Diabetes Metab. Rev. 4: 623-638, 1988.
28. Schoenle, E. J., P. D. Zenobi, T. Torresani, E. A. Werder, M. Zachmann, and E. R. Froesch. Recombinant human insulin-like growth factor I (rhIGF-I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia 34: 675-679, 1991.
29. Simmons, P. S., J. M. Miles, J. Gerich, and M. W. Haymond. Increased proteolysis: an effect of increases in plasma cortisol within the physiological range. J. Clin. Invest. 73: 412-420, 1984.
30. Tessari, P., S. L. Nissen, J. M. Miles, and M. W. Haymond. Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J. Clin. Invest. 77: 575-581, 1986.
31. Thompson, J. L., G. E. Butterfield, R. Marcus, R. L. Hinz, M. Van Loan, L. Ghiron, and A. R. Hoffmann. The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. J. Clin. Endocrinol Metab. 80: 1845-1852, 1994.
32. Turkalj, I., U. Keller, R. Ninnis, S. Vosmeer, and W. Stauffacher. Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid and leucine metabolism in man. J. Clin. Endocrinol. Metab. 75: 1186-1191, 1992.